QQ客服 官方微博 反馈留言

	miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer.
	Hongzhi Zhang; Huijuan Jiang; Huixiang Zhang; Juncai Liu; Xigang Hu; Lei Chen
刊名	OncoTargets and therapy
	2019
卷号	Vol.12页码:599-607
关键词	CD163 gastric carcinoma miR-4262 prognosis proliferation and invasion
ISSN号	1178-6930
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4743047
专题	湖南大学
作者单位	1.Department of Radiotherapy, Huaihe Hospital of Henan University, Kaifeng 475000, Henan, China, zhz_7607@12 2.com.
推荐引用方式 GB/T 7714	Hongzhi Zhang,Huijuan Jiang,Huixiang Zhang,et al. miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer.[J]. OncoTargets and therapy,2019,Vol.12:599-607.
APA	Hongzhi Zhang,Huijuan Jiang,Huixiang Zhang,Juncai Liu,Xigang Hu,&Lei Chen.(2019).miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer..OncoTargets and therapy,Vol.12,599-607.
MLA	Hongzhi Zhang,et al."miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer.".OncoTargets and therapy Vol.12(2019):599-607.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。